Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer

European Journal of Surgical Oncology

Volumn 41, Issue 3, 2015, Pages 333-338

  Tan, B H L ^a   Brammer, K ^a   Randhawa, N ^a   Welch, N T ^a   Parsons, S L ^a   James, E J ^a   Catton, J A ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Body composition; Chemotherapy toxicity; Oesophago gastric cancer; Sarcopenia

Indexed keywords

CAPECITABINE; CISPLATIN; EPIRUBICIN; FLUOROURACIL; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AGED; ARTICLE; BODY COMPOSITION; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; ESOPHAGOGASTRIC CANCER; ESOPHAGUS CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; SARCOPENIA; STOMACH CANCER; ADENOCARCINOMA; ANALOGS AND DERIVATIVES; CARCINOMA, SQUAMOUS CELL; COMPLICATION; ESOPHAGEAL NEOPLASMS; LOWER ESOPHAGUS SPHINCTER; MIDDLE AGED; PATHOLOGY; PROGNOSIS; STOMACH NEOPLASMS;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BODY COMPOSITION; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DEOXYCYTIDINE; EPIRUBICIN; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROGNOSIS; SARCOPENIA; STOMACH NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84922999366     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2014.11.040     Document Type: Article

References (29)

1. Cancer Research UK CancerStats: cancer statistics for the UK http://www.cancerresearchuk.org/cancer-info/cancerstats/ [accessed October 2013]
2. Medical Research Council Oesophageal Cancer Working Group Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial Lancet 359 9319 May 18 2002 1727 1733
3. W.H. Allum, S.P. Stenning, J. Bancewicz, P.I. Clark, and R.E. Langley Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer J Clin Oncol 27 30 Oct 20 2009 5062 5067
4. D. Cunningham, W.H. Allum, and S.P. Stenning Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 1 Jul 6 2006 11 20
5. O. Arrieta, R.M. Michel Ortega, and G. Villanueva-Rodriguez Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study BMC Cancer 10 2010 50
6. C.M. Prado, V.E. Baracos, and L.J. McCargar Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity Clin Cancer Res 13 11 Jun 1 2007 3264 3268
7. C.M. Prado, V.E. Baracos, and L.J. McCargar Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment Clin Cancer Res 15 8 Apr 15 2009 2920 2926
8. S. Antoun, V.E. Baracos, L. Birdsell, B. Escudier, and M.B. Sawyer Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma Ann Oncol 21 8 Aug 2010 1594 1598
9. P. Peng, O. Hyder, and A. Firoozmand Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma J Gastrointest Surg 16 8 Aug 2012 1478 1486
10. N. Harimoto, K. Shirabe, and Y.I. Yamashita Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma Br J Surg 100 11 Oct 2013 1523 1530
11. S.P. Psutka, A. Carrasco, and G.D. Schmit Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality Cancer 120 18 Sep 15 2014 2910 2918
12. L.H. Sobin, M.K. Gospodarowicz, C. Wittekind International Union against Cancer TNM classification of malignant tumours 7th ed. 2010 Wiley-Blackwell Chichester, West Sussex, UK; Hoboken, NJ
13. J.R. Siewert, and H.J. Stein Classification of adenocarcinoma of the oesophagogastric junction Br J Surg 85 11 Nov 1998 1457 1459
14. N. Mitsiopoulos, R.N. Baumgartner, S.B. Heymsfield, W. Lyons, D. Gallagher, and R. Ross Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography J Appl Physiol (1985) 85 1 Jul 1998 115 122
15. S.B. Heymsfield, Z. Wang, R.N. Baumgartner, and R. Ross Human body composition: advances in models and methods Annu Rev Nutr 17 1997 527 558
16. C.M. Prado, J.R. Lieffers, and L.J. McCargar Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study Lancet Oncol 9 7 Jul 2008 629 635
17. W. Shen, M. Punyanitya, and Z. Wang Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image J Appl Physiol (1985) 97 6 Dec 2004 2333 2338
18. M. Mourtzakis, C.M. Prado, J.R. Lieffers, T. Reiman, L.J. McCargar, and V.E. Baracos A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care Appl Physiol Nutr Metab 33 5 Oct 2008 997 1006
19. D. Du Bois, and E.F. Du Bois A formula to estimate the approximate surface area if height and weight be known. 1916 Nutrition 5 5 Sep-Oct 1989 303 311 discussion 312-303
20. D. Pinkel The use of body surface area as a criterion of drug dosage in cancer chemotherapy Cancer Res 18 7 Aug 1958 853 856
21. C.H. Takimoto Maximum tolerated dose: clinical endpoint for a bygone era? Target Oncol 4 2 Apr 2009 143 147
22. S.D. Baker, J. Verweij, and E.K. Rowinsky Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001 J Natl Cancer Inst 94 24 Dec 18 2002 1883 1888
23. A. Felici, J. Verweij, and A. Sparreboom Dosing strategies for anticancer drugs: the good, the bad and body-surface area Eur J Cancer 38 13 Sep 2002 1677 1684
24. T. Miya, T. Goya, and H. Fujii Factors affecting the pharmacokinetics of CPT-11: the body mass index, age and sex are independent predictors of pharmacokinetic parameters of CPT-11 Invest New Drugs 19 1 2001 61 67
25. A. Aslani, R.C. Smith, B.J. Allen, N. Pavlakis, and J.A. Levi The predictive value of body protein for chemotherapy-induced toxicity Cancer 88 4 Feb 15 2000 796 803
26. S. Awad, B.H. Tan, and H. Cui Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer Clin Nutr 31 1 Feb 2012 74 77
27. G. Cosqueric, A. Sebag, C. Ducolombier, C. Thomas, F. Piette, and S. Weill-Engerer Sarcopenia is predictive of nosocomial infection in care of the elderly Br J Nutr 96 5 Nov 2006 895 901
28. J. Alexandre, M. Gross-Goupil, and B. Falissard Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy Ann Oncol 14 1 Jan 2003 36 41
29. A. Pietrobelli, Z. Wang, and S.B. Heymsfield Techniques used in measuring human body composition Curr Opin Clin Nutr Metab Care 1 5 Sep 1998 439 448